title: Changing PET/CT manifestation of neurolymphomatosis.
authors.affiliation: Division of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland. klaus.strobel@usz.ch
authors.forename: Klaus
authors.initials: K
authors.lastname: Strobel
authors.forename: Bernhard
authors.initials: B
authors.lastname: Pestalozzi
authors.forename: Ilja
authors.initials: I
authors.lastname: Ciernik
authors.forename: Niklaus G
authors.initials: NG
authors.lastname: Schaefer
authors.forename: Abbas Yousefi
authors.initials: AY
authors.lastname: Koma
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Hany
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D008223:Lymphoma / Q000150:complications / Q000000981:diagnostic imaging*; D008875:Middle Aged; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D013382:Subtraction Technique; D014057:Tomography, X-Ray Computed; D051598:Whole Body Imaging
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18